400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / Syk / Syk Inhibitor II dihydrochloride
CAS No.: 227449-73-2
Synonyms: Spleen Tyrosine Kinase Inhibitor II
SYK inhibitor II is an inhibitor of SYK.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00665925 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT00665626 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT03010358 | Anemia B-Cell... more >> Prolymphocytic Leukemia Fatigue Fever Grade 1 Follicular Lymphoma Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma Hairy Cell Leukemia Lymphadenopathy Lymphocytosis Lymphoplasmacytic Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Night Sweats Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma Richter Syndrome Splenomegaly Thrombocytopenia Weight Loss Collapse << | Phase 1 Phase 2 | Recruiting | February 28, 2024 | United States, Oregon ... more >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Alexey V. Danilov 503-494-8426 danilov@ohsu.edu Principal Investigator: Alexey V. Danilov Collapse << |
实验方案
技术信息
CAS号 | 227449-73-2 | 储存条件 |
|
|
分子式 | C14H17Cl2F3N6O | 运输 | 蓝冰 | |
分子量 | 413.23 | 别名 | Spleen Tyrosine Kinase Inhibitor II |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00665925 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT00665626 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT03010358 | Anemia B-Cell... more >> Prolymphocytic Leukemia Fatigue Fever Grade 1 Follicular Lymphoma Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma Hairy Cell Leukemia Lymphadenopathy Lymphocytosis Lymphoplasmacytic Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Night Sweats Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma Richter Syndrome Splenomegaly Thrombocytopenia Weight Loss Collapse << | Phase 1 Phase 2 | Recruiting | February 28, 2024 | United States, Oregon ... more >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Alexey V. Danilov 503-494-8426 danilov@ohsu.edu Principal Investigator: Alexey V. Danilov Collapse << |
NCT00665925 | - | - | Completed | - | - |
NCT00665626 | - | - | Completed | - | - |
NCT03742258 | Diffuse Large B-Cell Lymphoma ... more >> Diffuse Large B-Cell Lymphoma Activated B-Cell Type Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements High Grade B-Cell Lymphoma, Not Otherwise Specified T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Collapse << | Phase 1 | Not yet recruiting | August 1, 2021 | United States, Illinois ... more >> Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Reem Karmali 312-695-0711 reem.karmali@northwestern.edu Principal Investigator: Reem Karmali Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网